Patients & Caregivers

Oral Mucositis

• About Oral Mucositis
• Patient Resources

Caphosol^®

• About Caphosol
• Using Caphosol
• Patient FAQ
• Request Patient Information

Support Programs

• Caphosol Home Delivery Program
• C-CASH Co-Pay Assistance Program - NEW!

Healthcare Professionals

• Product Information
• Healthcare Professional FAQ
• Safety Profile
• Prescribing Information
• Caphosol References
• Reimbursement Information
• Caphosol Speakers Bureau
• Request C-CASH Cards and Product Updates

Patient Programs

• Caphosol Home Delivery Program
• C-CASH Co-Pay Assistance Program - NEW!

References

1. Meraw, Stephen J., and Charles M. Reeve. Dental Considerations and Treatment of the Oncology Patient Receiving Radiation Therapy. Journal of the American Dental Association. 129 1998;201-205.
2. Rubenstein EB, Peterson DE, Schubert M, Keefe D, McGuire D, Epstein J, et al. Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis. Cancer. 2004;100(9 Suppl):2026-46.
3. Köstler WJ, Hejna M, Wenzel C, Zielinski CC. Oral mucositis complicating chemotherapy and/or radiotherapy: options for prevention and treatment. CA Cancer J Clin. 2001;51:290-315.
4. Sonis, Stephen T. Oral Mucositis in Cancer Therapy. Supportive Oncology 2. 2004;3-8.
5. Redding, Spencer W. Cancer Therapy-Related Oral Mucositis. Journal of Dental Education 69. 2005;919-929.
6. CAPHOSOL Prescribing Information.
7. Papas AS, Clark RE, Martuscelli G, O'Loughlin KT, Johansen E, Miller KB. A prospective, randomized trial for the prevention of mucositis in patients undergoing hematopoietic stem cell transplantation. Bone Marrow Transplant. 2003;8:705-12.
8. On-line Medical Dictionary. Mucositis. Centre for Cancer Education, University of Newcastle upon Tyne. Available at: http://cancerweb.ncl.ac.uk/cgi-bin/omd?query=mucositis. Accessed Jan. 22, 2007.
9. World Health Organization. Handbook for reporting results of cancer treatment. Geneva, Switzerland: World Health Organization, 1979.
10. Pico J-L et al. The Oncologist 1998;3(6):446-451.
11. Haas M et al. 50th ASTRO Congress 2008; abstract 2530.
12. Miyamoto C et al. Support Care Cancer 2009; 17:857-1039. A retrospective study of 21 head and neck cancer patients treated with intensity-modulated radiation therapy (IMRT) who received Caphosol from the start of their treatment. Outcomes were compared with 21 matched control patients who received standard care for oral mucositis.

Caphosol Safety Information:

• If Caphosol is swallowed accidently, no adverse effects are expected
• There are no known interactions with other medications
• Reported side effects have been rare and generally mild

Keep out of reach of children. For full prescribing information, please click here.

Home | About Oral Mucositis | About Caphosol | Using Caphosol | Patient FAQ
Patient Resources | Request Patient Information
Caphosol Home Delivery Program | C-CASH Co-Pay Program
Product Information for Healthcare Professionals | Safety Profile | Reimbursement Information
Register for Updates | Healthcare Professionals FAQ | Prescribing Info | Product News
References | Contact Us | Sitemap | Privacy Policy | Terms of Use | EUSA Pharma

Copyright ©2010 EUSA Pharma (USA), Inc. All rights reserved.